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yclopamine is a teratogenic steroidal alkaloid that causes cyclopia by blocking Sonic hedgehog (Shh) signal transduction.
e have tested whether this activity of cyclopamine is related to disruption of cellular cholesterol transport and putative
econdary effects on the Shh receptor, Patched (Ptc). First, we report that the potent antagonism of Shh signaling by
yclopamine is not a general property of steroidal alkaloids with similar structure. The structural features of steroidal
lkaloids previously associated with the induction of holoprosencephaly in whole animals are also associated with
nhibition of Shh signaling in vitro. Second, by comparing the effects of cyclopamine on Shh signaling with those of
ompounds known to block cholesterol transport, we show that the action of cyclopamine cannot be explained by inhibition
f intracellular cholesterol transport. However, compounds that block cholesterol transport by affecting the vesicular
rafficking of the Niemann–Pick C1 protein (NPC1), which is structurally similar to Ptc, are weak Shh antagonists. Rather
han supporting a direct link between cholesterol homeostasis and Shh signaling, our findings suggest that the functions of
oth NPC1 and Ptc involve a common vesicular transport pathway. Consistent with this model, we find that Ptc and NPC1
olocalize extensively in a vesicular compartment in cotransfected cells. © 2000 Academic Press
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Hedgehog family members are extracellular signaling
molecules involved in embryonic patterning in many ani-
mal phyla. In vertebrates, Sonic hedgehog (Shh) plays a
critical role in patterning of the neural tube. Notochord-
derived Shh mediates both the induction of ventral cell
types in the neural tube and the ventral exclusion of dorsal
cell types, and Shh released from the prechordal plate is
1 To whom correspondence should be addressed at the Depart-
ent of Biological Structure, University of Washington at Seattle,
ox 357420, HSB G527, Seattle, WA 98195. Fax: (206) 543-1524.
t-mail: roelink@u.washington.edu.
440equired for the induction of ventral cell types in the
orebrain (Tanabe and Jessell, 1996; Dale et al., 1997). Loss
f normal Shh function leads to a loss of ventral cell types
ll along the neural tube. This has significant conse-
uences, especially in the forebrain, which fails to divide
nto hemispheres (Chiang et al., 1996; Roessler et al., 1996).
n undivided forebrain, or holoprosencephaly, in its most
xtreme form is associated with cyclopia (for review, see
iebert et al., 1990; Roessler and Muenke, 1998).
Cyclopamine is one of a small group of steroidal alka-
oids, produced by Veratrum lily species, that induce holo-
rosencephaly and cyclopia in mammalian and avian em-
ryos. Cyclopamine causes holoprosencephaly by blocking
he response to Shh of cells normally sensitive to Shh. The
0012-1606/00 $35.00
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441Cyclopamine, Cholesterol Transport, and Shh Signalingloss of Shh responsiveness within the developing neural
tube, due to early embryonic exposure to cyclopamine,
results in a phenocopy of the Shh null mutant (Cooper et
l., 1998; Incardona et al., 1998). Our previous studies
emonstrated that a suite of Shh-dependent cell types in the
eural tube was affected in embryos with cyclopamine-
nduced holoprosencephaly. Furthermore, cyclopamine in-
ibits multiple Shh-mediated signaling events in other
issues at very different times of development, including
omites (Incardona et al., 1998), heart (J.P.I., unpublished
bservation), gut (Kim and Melton, 1998), limb/fin (Neu-
ann et al., 1999), and skin (Chiang et al., 1999).
Two decades of work by Keeler and colleagues demon-
trated that unique structural features of cyclopamine and
he related teratogenic compound jervine (Fig. 1) are re-
uired for the induction of holoprosencephaly in whole
nimal studies (reviewed in Gaffield and Keeler, 1996a,b).
ubtle changes in the structures of cyclopamine and jervine
ramatically affect their teratogenic potency, suggesting
hat a precise interaction with a target is required for their
nhibitory action. Since cyclopamine blocks the response to
hh, the cyclopamine target is likely to be involved in Shh
ignal transduction. Given the extreme hydrophobicity of
yclopamine and related compounds, we expect that their
arget is a membrane-associated protein, possibly an ele-
ent of the Shh receptor complex. Elements of the Shh
eceptor are the multiple membrane spanning proteins
atched (Ptc) and Smoothened (Smo), which act in concert
o mediate the Shh signal (Marigo et al., 1996; Stone et al.,
996; Chen and Struhl, 1998; for review, see Ingham, 1998;
urone et al., 1999). Shh binds to Ptc, which in turn
eleases the inhibition of Smo by Ptc, thus activating the
hh response.
The structural similarity between cyclopamine and cho-
esterol suggests a tantalizing potential mode of action of
yclopamine, especially in light of the association of holo-
rosencephaly, and thus attenuation of Shh signaling, with
enetic or pharmacologic impairment of enzymes involved
n the terminal steps of cholesterol biosynthesis. These
atter conditions produce both reduced levels of tissue
holesterol and high levels of sterol precursors (Tint et al.,
994; Kolf-Clauw et al., 1996). In particular, mutations in
he gene encoding D7-dehydrocholesterol (7-DHC) reduc-
ase (Fitzky et al., 1998) or inhibition of 7-DHC reductase
y the inhibitor AY-9944 promote mild forms of holo-
rosencephaly (Roux and Aubry, 1966; Kelley et al., 1996).
he simple hypothesis that both cyclopamine and AY-9944
nhibit the response of cells in the developing neural tube to
hh through the inhibition of cholesterol synthesis was
efuted, however, since AY-9944 is effective only when
esponding cells are deprived of exogenous cholesterol and
herefore have to rely on endogenously synthesized choles-
erol, while the action of cyclopamine is independent of the
ctivity of the cholesterol synthetic pathway (Incardona et
l., 1998). Accumulation of putatively teratogenic choles-
erol precursors, rather than cholesterol depletion, may
nderlie Shh-response inhibition by AY-9944. The b
Copyright © 2000 by Academic Press. All rightoloprosencephaly-inducing activity of cyclopamine is in-
ependent of cholesterol supply and is most likely mediated
FIG. 1. The structures of steroidal alkaloids and steroids tested for
inhibition of Shh signaling. The structure of cholesterol is shown at
top left and the generic jervane-type steroidal alkaloid structure is
at top right. Natural jervane alkaloids and synthetic derivatives are
listed below the generic structure, with differences indicated for
the functional groups R9 and R0, and for the type of C–C bond at
three variant positions. Cycloposine has a single glucose (glc)
residue in a glycosidic linkage to the 3-OH. Veratramine (middle,
left) occurs naturally and also is derived from cyclopamine by
electrophilic attack on the furan (E) ring under acidic conditions.
The spirosolane-type steroidal alkaloids solasodine and tomatidine
are represented by a generic structure (middle, right). These two
alkaloids differ only in the position of the N in the F ring (R9 and R0)
and in the level of saturation at C-5, C-6. Note the differences in
the E–F ring attachment to ring D between jervanes and spi-
rosolanes, which results in an orientation of the spirofuranopiperi-
dine moiety of cyclopamine perpendicular to the planar steroidal
framework. The glycoalkaloid saponins tomatine and solasonine
possess 4- and 3-residue oligosaccharides attached to the 3-OH
group of tomatidine and solasodine, respectively. The steroidal
amine U18666A [3b-(2-diethylaminoethoxy)androstenone] is repre-
ented at bottom left and progesterone at bottom right.y another mechanism.
s of reproduction in any form reserved.
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442 Incardona et al.In addition to cyclopamine and AY-9944, other com-
pounds disturbing cholesterol homeostasis reportedly in-
hibit the response to Shh (Cooper et al., 1998). These
ompounds include other hydrophobic amines and steroids
hat interfere with intracellular cholesterol trafficking,
uch as imipramine, progesterone, and U18666A (Liscum
nd Munn, 1999). This suggested the possibility that Shh
ignaling through Ptc is linked to cellular cholesterol ho-
eostasis, in particular to intracellular cholesterol trans-
ort (Cooper et al., 1998). A target for the hydrophobic
mines and steroids that block intracellular cholesterol
ransport may be the Niemann–Pick C1 (NPC1) protein
Neufeld et al., 1999). Treatment of cells with these com-
pounds induces a cellular cholesterol phenotype indistin-
guishable from that of cells from Niemann–Pick type C
(NP-C) patients, which lack the NPC1 protein (Liscum and
Faust, 1989; Rodriguez-Lafrasse et al., 1990; Roff et al.,
1991; Yoshikawa, 1991; Butler et al., 1992; Lange and Steck,
994). NP-C disease is a neurodegenerative lysosomal stor-
ge disorder, with an underlying and severe defect in
ntracellular transport of cholesterol and sphingolipids. Yet,
oss of NPC1 function by mutation is not associated with
ffects on Shh signaling: NP-C patients and NPC1-null
ice do not have congenital malformations. This suggests
hat the inhibition of Shh signaling by cyclopamine, hydro-
hobic amines, and steroids is not related to their effects on
ntracellular cholesterol transport. Comparison of Ptc and
PC1 protein sequences demonstrates a significant simi-
arity, largely, but not completely, confined to the
embrane-spanning regions (Carstea et al., 1997; Loftus et
l., 1997). This similarity includes a so-called “sterol-
ensing domain,” a pattern of conserved transmembrane
egions present in several other proteins involved in cho-
esterol homeostasis (Kumagai et al., 1995; Hua et al., 1996;
arstea et al., 1997; Loftus et al., 1997; Bae et al., 1999).
The similarity between Ptc and NPC1 suggests another
echanism by which hydrophobic amines and steroids
nterfere with Shh reception: not through their documented
ction on NPC1, but rather by acting on the same target as
yclopamine, a critical element of the Shh signal transduc-
ion cascade. It remains a good possibility that this target is
tc, given its homology to NPC1. A converse prediction of
his model is that cyclopamine and related compounds have
n effect on cholesterol homeostasis through their interac-
ion with NPC1 comparable to that of progesterone or
18666A.
To test these hypotheses we evaluated whether the
elative potencies of cyclopamine, structurally related ste-
oidal alkaloids that do not cause holoprosencephaly,
18666A, and progesterone to inhibit Shh signaling corre-
ate with their effects on cholesterol transport. The results
how a correlation between the attenuation of the Shh
esponse and the disruption of NPC1-mediated vesicular
rafficking. However, the relative concentrations of these
ompounds sufficient to perturb cholesterol trafficking and
oncentrations sufficient to block Shh signaling are very
ifferent. This suggests that the compounds act indepen- o
Copyright © 2000 by Academic Press. All rightently on targets within the Shh signaling pathway and the
PC1-mediated cholesterol transport pathway with vary-
ng efficiency. Our data suggest that the remarkable sensi-
ivity of Shh signal transduction to cyclopamine and the
ess potent effects of other compounds we tested reflect a
rimary effect on Ptc function. The structural similarities
f Ptc and NPC1 lead us to predict that Ptc mediates a
esicular trafficking process that is differentially sensitive
o many of the same pharmacological manipulations and is
rucial for Shh signal transduction.
MATERIALS AND METHODS
Materials. Veratrum steroidal alkaloids and their synthetic
derivatives were obtained as described previously (Brown and
Keeler, 1978; Gaffield et al., 1986). Progesterone was obtained from
Sigma (St. Louis, MO) and U18666A was obtained from BioMol
(Plymouth Meeting, PA). Steroidal alkaloids and progesterone were
dissolved in 95% ethanol; U18666A was dissolved in water.
Intermediate neural plate explants. Explants of intermediate
neural plate regions were isolated from Stage 9–10 chick embryos
and cultured in collagen gel as previously described (Yamada et al.,
993; Incardona et al., 1998). Explants were distributed in batches
f 10 onto pregelled collagen pillows and cultured at 37°C in
eurobasal medium supplemented with N3 mixture [N2 plus 10
M hydrocortisone (Bottenstein, 1992)], MEM nonessential amino
cids, penicillin/streptomycin, and 10 mM glucose. Test com-
ounds were diluted in Neurobasal medium. In general compounds
ere titrated to determine the highest concentration in which
xplants maintained viability for 12–14 h. Shh signaling was then
ssayed at the concentrations just below those causing complete
ell death within 12–14 h, but allowing viability to 30 h. Control
xplants were cultured with an equivalent concentration of solvent
0.1% or less). For assessment of the Shh response, explants were
arvested after 30 h of incubation, fixed in 4% paraformaldehyde,
nd processed for HNF-3b, Isl1/2, and Pax7 immunofluorescence as
escribed previously (Incardona et al., 1998). The response to Shh
as quantified by tallying positive nuclei with a hand counter for
t least 8 explants for each individual treatment.
For 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR)
ssays, 15 explants per well were tested in duplicate or triplicate.
o that more cellular material was assayed, slightly larger explants
hich included some dorsal and ventral regions were excised. After
4 h of incubation with the test compounds in the same medium as
bove, explants were washed with PBS, then quickly frozen in a dry
ce/ethanol bath and stored at 280°C until assayed.
Shh-N preparation. Assays utilized recombinant Shh-N, either
btained as conditioned medium from human 293T cells tran-
iently transfected with pShh-N as described previously (Roelink et
l., 1995) or partially purified from High-Five (Invitrogen, Carlsbad,
A) cells infected with a recombinant baculovirus expressing
hh-N (H.R., unpublished). The specific activity of each prepara-
ion was determined by titration in the explant assay, and the
hh-N protein content was estimated by comparison to a standard
fter SDS–PAGE and Coomassie blue staining. Some preparations
f Shh-N were shown to contain a fraction of material acylated at
n N-terminal Cys, which has a potency 30-fold higher than
nmodified Shh-N (Pepinsky et al., 1998). Our preparations most
ikely consisted of such a mixture, as suggested by the appearance
f a doublet band on Western blots (data not shown). Also consis-
s of reproduction in any form reserved.
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443Cyclopamine, Cholesterol Transport, and Shh Signalingtent with this, the baculovirus preparation used for most of the
experiments described here proved to be 10-fold more potent than
the bacterially expressed, unmodified protein originally used to
establish the Shh-N dose–response curve (Roelink et al., 1995;
Ericson et al., 1997). However, neither the N-terminal acylation
nor the C-terminal cholesterol modification of wild-type Shh is
required to assess the inhibitory activity of the compounds tested,
as similar results were obtained using bacterially expressed Shh-N
(Cooper et al., 1998).
HMGR and cholesterol esterification assays. Neural plate ex-
plants in collagen gels were processed and assayed for HMGR
activity as described previously (Plemenitas et al., 1990). Separate
aliquots of the cleared lysate were used for protein determination
(Giron et al., 1993). For measurement of cholesterol esterification,
rat hepatoma cells at confluency were pulse-labeled with [3H]cho-
lesterol and rinsed (Lange et al., 1993). Fresh medium containing
10% fetal bovine serum plus the test compounds or a solvent
control was added and the cells were incubated for 3 h at 37°C. The
cells were dissociated with trypsin, washed, extracted, and ana-
lyzed by TLC for the radioactivity in cholesterol and cholesteryl
esters (Lange et al., 1993).
Assay of accumulation of low-density lipoprotein (LDL)-
cholesterol in lysosomes. Normal human fibroblasts were seeded
into two well chamber slides at 20,000 cells/well in McCoy’s
medium supplemented with 5% lipoprotein-deficient serum and
antibiotics (LPDS-McCoy’s). After 4 days the cells were cultured
for 24 h in LPDS-McCoy’s containing the steroidal alkaloids or
progesterone (all dissolved in ethanol; final ethanol concentration
was ,0.1%) and LDL. The cells were then fixed and processed for
filipin/cholesterol histochemistry as previously described
(Blanchette-Mackie et al., 1988). LPDS and purified human LDL
ere obtained from Intracel (Rockville, MD).
DNAs, transfections, and immunofluorescence. The full-
ength cDNA encoding chick Ptc-1 tagged with the influenza HA
pitope (PtcHA) has been described previously (Marigo et al., 1996).
he PtcHA coding sequence was subcloned into pMT21 for expres-
ion in mammalian cells and was shown to function in endocytosis
f Shh (Incardona et al., submitted for publication). The full-length
uman NPC1 cDNA contained in pSV-SPORT-1 was described
reviously and shown to restore normal cholesterol transport in
PC1-deficient cells (Watari et al., 1999). COS-1 cells, cultured in
MEM 1 10% fetal bovine serum, were transfected with PtcHA
nd/or NPC1 constructs using Lipofectamine (Gibco BRL, Be-
hesda, MD) according to the manufacturer’s directions. Twenty-
our hours after transfection cells were trypsinized and seeded onto
oly-D-lysine-coated coverslips. At 48 h after transfection cells
ere washed with PBS and fixed in 4% MEM-buffered paraformal-
ehyde. After being washed with PBS and blocked in PBS 1 0.1%
riton X-100 1 5% normal serum, cells were incubated for 1 h at
oom temperature in primary antibodies, washed with PBS 1 0.1%
riton X-100, then incubated for 1 h at room temperature in
econdary antibodies. Primary antibodies were FITC-conjugated
nti-HA monoclonal 12CA5 (Boehringer Mannheim) at 1:50 or
nti-HA rat monoclonal (Boehringer Mannheim) at 1:250 and rabbit
nti-human NPC1 polyclonal antibodies at 1:500 (Neufeld et al.,
999). Secondary antibodies (Jackson ImmunoResearch) were
exas red-conjugated anti-rat IgG and FITC-conjugated anti-rabbit
gG. After final washes cells were mounted in 50% glycerol in 0.1
sodium carbonate, pH 9.5, with a trace of phenylenediamine to
revent bleaching. Confocal images were obtained on a Bio-Rad
RC600.
Copyright © 2000 by Academic Press. All rightRESULTS
The Neural Plate Explant Assay
Chick embryo neural plate explants were cultured in the
presence of Shh-N, which leads to the induction of markers
for floor plate (HNF3b) and motor neuron (Isl1/2) differen-
tiation, as well as repression of a marker for dorsal precursor
cells (Pax7) (Roelink et al., 1995; Ericson et al., 1997;
Briscoe and Ericson, 1999). In a typical Shh-N dose re-
sponse, HNF-3b1 floor plate cells are maximally induced
by 1–2 nM Shh-N, Isl1/21 motor neurons are maximally
induced by 0.3–0.5 nM Shh-N, and Pax71 dorsal precursor
cells are repressed by 0.05–0.1 nM Shh-N. Thus, at the
highest Shh-N concentrations, HNF-3b induction predomi-
nates, although this is at the expense of Isl1/21 cells
(typically 60–100 Isl1/21 cells and 1000–1200 HNF-3b1
cells). Isl1/21 cells are maximally induced (typically 200–
300 cells in a 1500-cell explant) at concentrations of Shh-N
that induce few or no HNF-3b1 cells. Even lower concen-
rations of Shh-N repress Pax7 in the absence of Isl1/2 or
NF-3b induction. Therefore, the number of HNF3b cells
is a straightforward, but somewhat less sensitive indicator
of Shh signaling. The Shh-dependent induction of Isl1/2 is
more sensitive, but maximum response occurs in a rela-
tively narrow dose range, with the number of Isl1/21 cells
per explant decreasing both at higher and at lower Shh
concentrations and can thus be used as a reliable quantita-
tive indicator of the Shh response only in conjunction with
Pax7 or HNF3b induction.
At a constant high Shh-N concentration (2.5 nM), the
yclopamine dose response mimics a reverse of the Shh-N
ose response (Roelink et al., 1995; Ericson et al., 1997).
Induction of HNF-3b1 cells is reduced and more Isl1/21
cells appear at low concentrations of cyclopamine (12–24
nM); at intermediate cyclopamine concentrations HNF-3b
induction is completely blocked (24–48 nM), while Isl1/2
induction persists; at higher cyclopamine concentrations
both HNF-3b and Isl1/2 induction is blocked, while some
ax7 repression persists (60 nM); all signaling is blocked by
20 nM cyclopamine (Fig. 3, data not shown and Incardona
t al., 1998). Because each marker (HNF3b, Isl1/2, and Pax7)
responds maximally to a different threshold Shh-N concen-
tration, comparisons of the inhibitory activity of the differ-
ent compounds are most straightforward using a single
marker. Although in general we tested the effects of most of
the compounds on all three markers, only data for HNF3b
are shown.
Steroidal Alkaloids Have Specific Structural
Requirements for Inhibition of Shh Signaling
To determine if Keeler and colleagues’ results reflected an
interaction with a proximate target within the Shh signal-
ing pathway, or differences in whole-animal pharmacoki-
netics, we tested many of their same collection of steroidal
alkaloids both in the neural plate explant assay and by
direct application to chick embryos (data not shown). To
s of reproduction in any form reserved.
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444 Incardona et al.make structure/activity correlations with derivatives of
cyclopamine and other steroidal alkaloids, explants were
challenged with increasing amounts of the compounds, and
a block in the response to Shh-N was measured by the loss
of HNF3b1 (Fig. 2) and Isl1/21 (data not shown) cells in
explants. The effects of the compounds on Isl1/2 induction
were consistent with that observed for HNF3b induction,
escribed below.
A critical structural feature associated with the induction
f holoprosencephaly is the E ring (Fig. 1), which is at a right
ngle in relation to the A–D rings. This furan E ring is easily
pened under acidic conditions, yielding veratramine (Fig.
), which does not induce holoprosencephaly. Steroidal
lkaloids such as tomatidine and solasodine (Fig. 1), which
ontain an E ring in the same plane as the A–D rings, have
ery low teratogenicity and also do not induce holoprosen-
ephaly in hamsters (Gaffield and Keeler, 1996b). In con-
rast to the complete block in HNF3b induction by 120 nM
cyclopamine, only partial loss of HNF3b1 cells is achieved
t 2.4 mM veratramine, tomatidine, and solasodine (Fig. 2).
Concentrations of solasodine and veratramine higher than
10 mM were toxic to explant cells, and tomatidine at 24 mM
roduced only minimal inhibition of Isl1/2 induction and
FIG. 2. Structure/activity correlation for the inhibition of Shh
ignaling by steroidal alkaloids. VER, veratramine; TOM, tomati-
ine; SOL, solasodine; JER, jervine; 4-en-3-one, cyclopamine-4-en-
-one; THJ, tetrahydrojervine; CpO, cycloposine. Chick neural
late explants were cultured with 2.5 nM Shh-N and the indicated
oncentrations of steroidal alkaloids and processed for HNF-3b and
sl1/2 (data not shown) immunofluorescence. Values represent the
ercentage of the mean HNF-3b1 nuclei and SEM counted in
control explants treated with 2.5 nM Shh-N and solvent alone.
Control explants had (mean 6 SE) 765 6 62 HNF3b1 nuclei and
77 6 11 Isl1/21 nuclei.ax7 repression (data not shown). These latter steroidal
Copyright © 2000 by Academic Press. All rightlkaloids thus affect Shh signaling at a concentration 100-
old above that sufficient to obtain comparable inhibition
y cyclopamine, but are unable to completely block signal-
ng. Similarly, application of 5 mg tomatidine or solasodine
to chick embryos in ovo resulted in 1or 2 of 60 embryos
ith mild holoprosencephaly and minor defects in the floor
late at cervical levels (data not shown), suggesting that
eratogenic concentrations are achieved in embryos only
arely. In contrast, malformations in cyclopamine-treated
mbryos are much more common and show greater severity
oth grossly and at the molecular level (Incardona et al.,
998). Therefore, the in vitro and in ovo effects on Shh
signaling for steroidal alkaloids with E–F ring structures
different from cyclopamine are consistent with their
weaker teratogenicity.
In addition to the E–F ring system, changes in both
polarity and steric bulk of the planar steroid ring system
also affect teratogenic potency. When administered by
gavage to hamsters, jervine was consistently more potent
than cyclopamine (Gaffield and Keeler, 1996b). This is
likely due to the greater resistance of jervine to stomach
acid-catalyzed opening of the furan ring than cyclopamine
(Gaffield and Keeler, 1996a), resulting in a higher effective
dose in whole animals (Fig. 1). However, jervine is a weaker
teratogen in chick embryos, producing fewer holoprosence-
phalic embryos (data not shown), and 5- to 10-fold less
potent than cyclopamine in the explant assay, producing an
incomplete (90%) block of HNF-3b induction (Fig. 2) at 240
nM. In contrast, oxidation of the 3-OH in cyclopamine to
produce cyclopamine-4-en-3-one (Fig. 1) resulted in en-
hanced potency in the hamster assay (Brown and Keeler,
1978), and this derivative produced a near-complete inhibi-
tion of Shh signaling in explants at 48 nM (Fig. 2).
Cyclopamine-4-en-3-one appears to be at least 2-fold more
potent than cyclopamine in the explant assay.
Other structural changes of the planar ring system also
produced a loss of potency in the hamster assay (Brown and
Keeler, 1978; Gaffield and Keeler, 1993). Reduction of the
C-5, C-6 and C-12, C-13 double bonds of jervine produced
the weaker teratogen, tetrahydrojervine (Fig. 1). Tetrahy-
drojervine is about threefold weaker than jervine at block-
ing HNF-3b induction in explants (Fig. 2), producing 43%
inhibition at 240 nM. Finally, cycloposine, a glycoalkaloid
analog of cyclopamine bearing a single glucose bonded to
the 3-OH (Fig. 1), was found to be considerably weaker than
cyclopamine in the explant assay (Fig. 2), but comparable to
jervine. The reduction in potency secondary to the glyco-
sidic attachment at the 3-OH suggests that cyclopamine
does not act by binding to sterols: removal of sugar residues
is known to prevent the interaction of steroidal glycoalka-
loids with sterols (Roddick, 1979).
Overall, these data show that the relative teratogenic
potencies for steroidal alkaloids in the hamster assay (Gaf-
field and Keeler, 1996a,b) are very similar to their relative
abilities to block Shh signaling in explants, with a trivial
exception, the acid-catalyzed conversion of cyclopamine to
veratramine in the nonruminant mammalian stomach. The
s of reproduction in any form reserved.
a
p
a
d
b
(
H
c
n
t
S
U
445Cyclopamine, Cholesterol Transport, and Shh Signalingsignificant teratogenic potencies and precise structural re-
quirements of certain steroidal alkaloids likely reflect a
specific interaction with a component of the Shh signaling
pathway.
To further exclude the possibility that the Shh-inhibiting
actions of cyclopamine and related compounds are indi-
rectly caused by interference with cholesterol homeostasis,
we tested well-known cholesterol transport blockers for
their capacity to inhibit the Shh response in neural plate
explants in vitro.
The Prototypical Cholesterol Transport Blockers
U18666A and Progesterone Are Weak
Shh-Response Inhibitors
Using the explant assay, we compared the effects of
cyclopamine to those of two compounds, U18666A and
progesterone, with known effects on cholesterol transport,
most likely as a consequence of their blocking of normal
NPC1 function (Higgins et al., 1999; Neufeld et al., 1999;
nd Y. Lange, unpublished observations). U18666A and
rogesterone were reported to block the response to Shh-N
t concentrations of 0.25 and 20 mM, respectively (Cooper
et al., 1998). A more detailed analysis revealed that
U18666A and progesterone inhibit Shh signaling only par-
FIG. 3. Comparison of Shh-response inhibition by cyclopamine,
U18666A, and progesterone. Chick neural plate explants were
cultured with 2.5 nM Shh-N and the indicated concentrations of
cyclopamine, U18666A, and progesterone and processed for
HNF-3b and Isl1/2 immunofluorescence as described under Mate-
rials and Methods. Values represent the mean numbers and SEM of
nuclei counted for HNF3b, expressed as the percentage of the mean
nuclei counted in control explants treated with 2.5 nM Shh-N and
solvent alone. In the U18666A experiments, control explants had
(mean 6 SEM) 1552 6 100 HNF3b1 nuclei and 71 6 8 Isl1/21
nuclei; in the progesterone experiments, control explants had
750 6 47 HNF3b1 nuclei and 28 6 5 Isl1/21 nuclei.tially at those concentrations and cannot completely in-
Copyright © 2000 by Academic Press. All righthibit responses to Shh-N, even at higher concentrations
near the toxic threshold (Fig. 3). Although inhibition of
HNF3b induction is detected with low concentrations of
U18666A (80% of control at 0.048 mM), HNF3b1 cells were
etected in explants treated with 0.48 mM U18666A (19%
of control), and Isl1/2 induction persisted at high levels
(443% of control; data not shown). At U18666A concentra-
tions of 2.4 mM HNF3b induction was completely blocked,
ut Isl1/2 induction still persisted at 33–66% of controls
data not shown). Concentrations higher than 2.4 mM were
too toxic for explants.
Progesterone proved to be an even weaker inhibitor of
Shh signaling at very high concentrations relative to cyclo-
pamine (Fig. 3). At 10 mM progesterone had only a moderate
inhibitory effect on HNF-3b induction (68% of control),
while increasing Isl1/2 induction (data not shown). Proges-
terone at 30 mM produced a more significant inhibition of
NF-3b (5%), but significant Isl1/2 induction remained
(67% of control, data not shown). Higher concentrations of
progesterone killed the explants within 12 h. Progesterone
and U18666A were, thus, unable to block all of the Shh
responses without significant toxicity, and the concentra-
tions of progesterone and U18666A that maximally inhib-
ited Shh signaling (30 and 2.4 mM, respectively) produced
onsiderable cell death at the periphery of the explants (data
ot shown). In contrast, the cell death observed in explants
reated with 0.12 mM cyclopamine was comparable to that
of explants cultured without Shh-N (data not shown),
consistent with the complete block in Shh signaling. As
summarized in Table 1, we estimated the IC50s for inhibi-
tion of HNF3b induction by many of the compounds.
TABLE 1
Comparison of IC50s for Inhibition of HNF3b Induction and
Esterification of Cholesterol at the Endoplasmic Reticulum
Drug
IC50 HNF3b
inhibitiona
IC50 esterification
inhibitionb
Cyclopamine 0.01 mM 9 mM
Jervine 0.08 mM 7 mM
Veratramine 3 mM 3 mM
Tomatidine 2 mM 15 mM
olasodine 1 mM 15 mM
18666A 0.1 mM 0.1–0.5 mMc
Progesterone 15 mM 3 mMd
a IC50s were estimated from plots similar to that shown in Fig. 3.
b Incorporation of [3H]cholesterol into esters was measured in rat
hepatoma cells as described under Materials and Methods. IC50s
were estimated by plotting the percentage of esterified cholesterol
in cells treated with concentrations of steroidal alkaloids ranging
from 0.1 to 40 mM, relative to control cells incubated with ethanol
solvent only. Values were obtained from triplicate measurements
with SEM within 10%.
c Underwood et al., 1996.
d Lange and Steck, 1994.
s of reproduction in any form reserved.
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446 Incardona et al.Veratramine and the spirosolane steroidal alkaloids are
roughly 100-fold weaker inhibitors than cyclopamine,
U18666A is about 10-fold weaker, and progesterone is about
1000-fold weaker. If these compounds act indirectly on Shh
signaling by interfering with cholesterol homeostasis in
responding cells, there should be a similar correlation
between the ability of each compound to inhibit the Shh
response and the ability to block cholesterol transport.
The Ability of Steroidal Alkaloids and Steroids to
Block Cholesterol Transport Does Not Correlate
with Their Ability to Inhibit Shh Signaling
Under normal conditions, LDL-associated cholesterol is
internalized by cells and subsequently distributed to vari-
ous parts of the cell through an active process. Inhibition of
intracellular cholesterol transport is manifested by several
changes in cholesterol homeostasis that can be quantified:
(1) increased activity of HMGR, the rate-limiting enzyme in
cholesterol biosynthesis, due to reduced traffic of choles-
terol to the ER, and thus ER cholesterol levels; (2) inhibition
of esterification of cholesterol in the ER, also reflecting
reduced cholesterol trafficking to the ER; and (3) accumu-
lation of internalized LDL-cholesterol in lysosomes, due to
the failure of normal redistribution of internalized LDL-
cholesterol from late endosomes. Although the precise
cholesterol transport pathway(s) measured by these assays
are incompletely characterized, the assays provide comple-
mentary information and overall produce similar results.
Using these three assays, we found that at relatively high
concentrations, all steroidal alkaloids have similar effects
on cholesterol homeostasis and that a concentration of
cyclopamine sufficient to completely block Shh signaling
does not disrupt cholesterol transport in neural plate cells.
HMGR levels were measured in chick neural plate ex-
plants treated with 2.5 nM Shh-N and various compounds.
Treatment with Shh-N alone (data not shown), plus 120 nM
cyclopamine, sufficient to completely block Shh respon-
siveness, or 120 nM veratramine had no significant effect
on explant HMGR levels (Fig. 4). Therefore, the complete
inhibition of Shh signaling in explants is not coupled to a
corresponding block in cholesterol transport to the ER. In
contrast, treatment of explants with 120 nM U18666A
resulted in a 4-fold increase in HMGR activity (Fig. 4),
although this concentration of U18666A induces only a
partial block of Shh signaling (Fig. 3). Progesterone at 30 mM
produced a nearly 10-fold increase of HMGR activity (Fig.
4), but likewise, this concentration of progesterone pro-
duced only an incomplete block of Shh signaling (Fig. 3).
Thus even when movement of cholesterol to the ER is
significantly blocked by U18666A or progesterone, some
Shh signaling still occurs. Overall, there is little correlation
between a compound’s ability to inhibit cholesterol trans-
port, as it relates to upregulation of HMGR activity in
neural plate cells, and its ability to block Shh signaling,
indicating that the inhibition of cholesterol transport and
Copyright © 2000 by Academic Press. All rightnhibition of Shh signal response are mediated via distinct
argets.
To determine if the observed IC50s for HNF3b induction
correlated with IC50s for inhibition of cholesterol transport,
e utilized an assay of ER cholesterol esterification in a
ammalian cell line (Table 1), since neural plate explants
rovide only very small amounts of tissue. At a cyclopamine
oncentration sufficient to completely block Shh response,
here was no effect on esterification of plasma membrane-
erived cholesterol (data not shown). At much higher con-
entrations cyclopamine and jervine had very similar ef-
ects on cholesterol esterification, with IC50s of 9 and 7 mM,
espectively. Veratramine, which does not induce holo-
rosencephaly, was slightly more potent, with an IC50 near
mM. All three jervane steroidal alkaloids produced an
80–90% block of cholesterol esterification at 12 mM (data
ot shown), which is near the toxic threshold for most cell
ypes. The spirosolane steroidal alkaloids (tomatidine and
olasodine) were slightly weaker inhibitors of cholesterol
sterification, with virtually identical IC50s of 15 mM.
owever, these compounds are orders of magnitude weaker
han cyclopamine in Shh signaling inhibition. The signifi-
ant differences in teratogenicity among the steroidal alka-
oids are not reflected in their capacity to block esterifica-
ion of cholesterol. However, the published IC50s for
nhibition of cholesterol esterification by U18666A and
rogesterone (Table 1) are relatively close to the concentra-
ions at which they inhibit Shh signaling, although proges-
erone appears to be weaker at inhibition of Shh signaling
han inhibition of cholesterol esterification.
FIG. 4. Effects of steroidal alkaloids, U18666A, and progesterone
compounds on HMGR activity in neural plate cells. Chick neural
plate explants were cultured for 24 h in 2.5 nM Shh-N and the
indicated concentrations of cyclopamine (CpA), veratramine (VER),
U18666A (U), and progesterone (PG). HMGR activity was deter-
mined as described under Materials and Methods. The values
represent the means 6 SEM HMGR specific activity.Similar results were observed for accumulation of LDL-
s of reproduction in any form reserved.
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447Cyclopamine, Cholesterol Transport, and Shh Signalingcholesterol in lysosomes of cultured cells, assayed by filipin
cytochemistry (Fig. 5 and Table 2). Cyclopamine and toma-
tidine were found to have very similar effects on trafficking
of lysosomal LDL-cholesterol. A moderate accumulation of
FIG. 5. Accumulation of lipoprotein-derived cholesterol in lysos
cholesterol was visualized by fluorescent filipin staining as des
magnifications of fields of cells. Accumulation of cholesterol is a
surrounding nuclei. In C, E, and G, cells with no cholesterol accum
accumulation indicated with the arrow, and cells with high accum
in each field have high accumulation of cholesterol in lysosome
challenged with LDL (Blanchette-Mackie et al., 1988). Cells treated
as control cells (data not shown), but cells treated with 0.12 mM ver
represents 50 mm.
TABLE 2
Quantification of the Accumulation of LDL-Cholesterol in
Lysosomes Induced by Steroidal Alkaloids and Progesterone
Drug
Concentration
(mM)
Filipin1 cells/total
(percentage)
None N/A 2/27 (7)
Veratramine 0.12 18/27 (67)
12 25/25 (100)
Cyclopamine 1.2 17/28 (61)
12 27/27 (100)
Tomatidine 1.2 19/33 (58)
12 28/28 (100)
Progesterone 30 29/29 (100)
Copyright © 2000 by Academic Press. All rightholesterol was produced by 1.2 mM cyclopamine (Fig. 5C),
bserved in 61% of treated cells, and 1.2 mM tomatidine
(Fig. 5G), in 58% of treated cells. Both compounds at 12 mM
(Figs. 5D and 5H, respectively) produced a maximal effect
comparable to 30 mM progesterone (Fig. 5B), with 100% of
reated cells showing filipin1 lysosomes. Veratramine was
ignificantly more potent in this assay, producing a moder-
te cholesterol accumulation at 0.12 mM (Fig. 5E), with 67%
of treated cells showing filipin1 lysosomes.
All the steroidal alkaloids tested thus have roughly simi-
lar cholesterol transport blocking activity, with veratra-
mine more potent in some assays. These data are consistent
with observations that most hydrophobic amines can block
cholesterol transport, but clearly indicate that effects on
intracellular cholesterol trafficking do not correlate with
their teratogenic potency in blocking the Shh response. It is
notable, however, that NPC1 appears to play a key role in
the cholesterol trafficking pathway(s) measured by these
three assays, as defects in each are observed in cells from
NP-C patients. Because some of these drugs may affect a
of cultured fibroblasts induced by steroidal alkaloids. Lysosomal
d under Materials and Methods. The images show low-power
ent by the fluorescent signal in lysosomes within the cytoplasm
ion are indicated with the unfilled arrowhead, cells with moderate
ion indicated with the filled arrowhead. In B, D, F, and H all cells
lls carrying NPC1 mutations appear identically when similarly
h 0.12 mM cyclopamine or 0.12 mM tomatidine appeared the same
ine showed significant lysosomal filipin staining (E). Scale bar (G)omes
cribe
ppar
ulat
ulat
s. Ce
wit
atramvesicular compartment linked to NPC1 function (Higgins
s of reproduction in any form reserved.
H
t
S
d
m
c
d
e
c
e
t
c
w
s
fl
p
1
a
p
f
c
p
N
q
a
t
l
m
p
S
t
b
s
b
p
i
e
a
n
c
t
u
o
s
o
e
s
f
i
a
t
p
s
p
l
s
f
e
e
a
a
i
d
l
m
P
m
p
s
t
i
m
t
a
R
c
N
448 Incardona et al.et al., 1999; Kobayashi et al., 1999; Neufeld et al., 1999;
oltta-Vuori et al., 2000; Watari et al., 2000), it is possible
hat this same compartment is linked to Ptc function and
hh signaling.
Ptc-1 and NPC1 Colocalize Extensively
in Transfected Cells
NPC1 is normally found on cytoplasmic vesicles with
late endosomal characteristics (Higgins et al., 1999;
Neufeld et al., 1999; Holtta-Vuori et al., 2000; Watari et al.,
2000). In the Drosophila embryo Ptc is found on multive-
sicular bodies, indicating that it is present in a late endo-
cytic compartment (Capdevila et al., 1994). Recent evi-
ence suggests that Ptc-1, the vertebrate Ptc-family
ember expressed in neural plate cells, mediates the endo-
ytosis of Shh during signaling in neural plate cells (Incar-
ona et al., submitted for publication). In transfected cells,
pitope-tagged Ptc-1 (PtcHA) is found predominantly intra-
ellularly (Fig. 6A), with a significant component present in
ndocytic vesicles (Incardona et al., submitted for publica-
ion). Although PtcHA is essentially undetectable at the
ell surface, PtcHA-expressing cells rapidly internalize Shh,
hich colocalizes with PtcHA in vesicles (Incardona et al.,
ubmitted for publication). The pattern of PtcHA immuno-
uorescence is virtually identical to that of NPC1 overex-
ressed in the same cell type (Fig. 6B and Higgins et al.,
999), with immunolabeled vesicles of 0.5–1 mm diameter
ppearing peripherally in filopodia, as well as a prominent
erinuclear cluster of positive vesicles. In cells cotrans-
ected with PtcHA and NPC1 constructs, both proteins
olocalize extensively in peripheral vesicles and in the
erinuclear region (Figs. 6C–6E), suggesting that Ptc-1 and
PC1 are targeted to the same compartment(s).
DISCUSSION
It was recently proposed that defects in intracellular
cholesterol transport and homeostasis are the common
basis for the induction of holoprosencephaly by cyclopamine
and the 7-DHC reductase inhibitor AY-9944 (Cooper et al.,
1998). This hypothesis was based on the findings that
compounds known to block intracellular cholesterol trans-
port also inhibited Shh signaling in vitro and that high
concentrations of both AY-9944 and cyclopamine could
also block cholesterol transport. Our data do not support
this hypothesis for the following reasons: (1) Among the
compounds tested, only cyclopamine completely blocked
Shh signaling in the absence of cytotoxicity, and terato-
genic concentrations did not block cholesterol transport in
neural plate cells. (2) Cyclopamine and steroidal alkaloids
with weak Shh inhibitory activity were generally equipo-
tent in assays of cholesterol transport. (3) U18666A and
progesterone are weak Shh antagonists, despite markedly
affecting cholesterol homeostasis in neural plate explants.The unique structure of cyclopamine is absolutely re- g
Copyright © 2000 by Academic Press. All rightuired for induction of holoprosencephaly in whole animals
nd to block Shh signaling in vitro. In contrast, the struc-
ural requirements associated with inhibition of intracellu-
ar cholesterol transport are different. Although the large
ajority of compounds with this activity are simply hydro-
hobic amines with very diverse structures (Lange and
teck, 1994), there is significant structural specificity for
he inhibition of cholesterol transport by steroids, indicated
y the potency of progesterone relative to other natural
teroids (Butler et al., 1992). Moreover, U18666A, which is
oth a hydrophobic amine and a steroid, is one of the most
otent blockers of cholesterol transport, with an IC50 rang-
ng from 100 to 800 nM depending on the assay (Underwood
t al., 1996). Nevertheless, both progesterone and U18666A
re relatively weak Shh antagonists, but U18666A is sig-
ificantly more potent than progesterone. Although high
oncentrations of cyclopamine can inhibit cholesterol
ransport, we believe that this activity reflects a side effect
nrelated to inhibition of Shh signaling.
The effects of cyclopamine on both embryos treated in
vo and neural plate explants must reflect inhibition of the
ignal transduction cascade at a very early point. Activation
f Shh target genes in neural precursors occurs through
ither of at least two downstream branches: HNF3b expres-
ion in the floor plate is controlled by Gli transcription
actors, whereas induction of motor neuron-specific genes
s independent of Gli function (Ding et al., 1998; Matise et
l., 1998; Park et al., 2000) and appears to involve another
ranscription factor (Krishnan et al., 1997a,b). Because floor
late and motor neuron inductions are both remarkably
ensitive to inhibition by cyclopamine, the target of cyclo-
amine must be proximal to the bifurcation in the pathway
eading to these distinct fates. Other elements of the Shh
ignaling cascade that are upstream of and influence Gli
unction include Fused and Suppressor of fused (Carpenter
t al., 1998; Ding et al., 1999; Kogerman et al., 1999; Pearse
t al., 1999; Stone et al., 1999). The fly homolog of Gli, Ci,
lso interacts with Costal2 (Robbins et al., 1997; Sisson et
l., 1997), but no vertebrate Costal2 homolog has been
dentified. A role for any of these elements in motor neuron
evelopment has not been demonstrated, but it seems
ikely that cyclopamine acts upstream of their involve-
ent. The only other upstream factors known to date are
tc and Smo.
The simplest model explaining our data is a common
echanism of inhibition by cyclopamine, U18666A, and
rogesterone. It is unlikely that perturbation of Shh respon-
iveness is a direct or indirect consequence of NPC1 an-
agonism because Shh signaling is intact in embryos lack-
ng NPC1. No malformations are associated with NPC1
utations in humans or mice, although defects in choles-
erol transport can be detected at fetal stages (de Winter et
l., 1992; Vanier et al., 1992; Dumontel et al., 1993;
odriguez-Lafrasse et al., 1994). Moreover, defects in intra-
ellular cholesterol distribution similar to that observed in
P-C cells were recently associated with several otherenetic lipid storage diseases (Puri et al., 1999), none of
s of reproduction in any form reserved.
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449Cyclopamine, Cholesterol Transport, and Shh Signalingwhich are known to produce defects in Shh signaling. Why
would Shh signaling be inhibited as a consequence of
pharmacologic disruption of intracellular cholesterol trans-
port, but not genetic disruption of the same pathways? The
relationship of Ptc to NPC1 and the known effects of
U18666A and progesterone on NPC1 function suggest that
Ptc function is the direct or indirect target of these com-
pounds in the Shh signaling pathway.
We favor the hypothesis that a common vesicular traf-
FIG. 6. Immunolocalization of PtcHA and NPC1 in transfected ce
s described under Materials and Methods. Each panel shows a hi
ransfected with human NPC1 alone. NPC1 immunofluorescence
ellular processes and in a cluster near the nucleus (nu). (B) A cell
n numerous vesicles within cellular processes, as well as in a clust
tructures with a more tubulovesicular appearance that may indi
PC1 and PtcHA. PtcHA (C, green) and NPC1 (D, red) colocalize e
s in the perinuclear region, as shown by yellow signal in the merficking pathway may underlie both cholesterol transport a
Copyright © 2000 by Academic Press. All rightnd the regulation of Shh signaling by Ptc. This might
xplain the disruption of Shh signaling by drugs that block
holesterol transport (U18666A, progesterone), as it is
nown that intracellular trafficking of NPC1 is dramati-
ally affected by the same agents (Higgins et al., 1999;
eufeld et al., 1999). On the contrary, loss of one passenger
n this pathway (e.g., NPC1) by mutation would not be
xpected to disrupt the trafficking of another (Ptc). Al-
hough the IC50s for inhibition of both cholesterol transport
OS-1 cells were transfected and processed for immunofluorescence
agnification confocal image of a single transfected cell. (A) A cell
vident as punctate signal representing numerous vesicles within
sfected with PtcHA alone. PtcHA immunofluorescence is evident
ar the nucleus (nu). The perinuclear signal in this cell also includes
Golgi-associated protein. (C–E) A cell cotransfected with human
sively in both peripheral vesicles within cellular processes as well
mage (E). Scale bar represents 10 mm.lls. C
gh-m
is e
tran
er ne
cate
xtennd HNF3b induction are similar for both U18666A and
s of reproduction in any form reserved.
450 Incardona et al.progesterone, the idea that these two compounds affect Shh
signaling via inhibition of cholesterol transport is not
supported by the genetic data.
The extensive colocalization of PtcHA and NPC1 and the
potential role of endocytic trafficking of Shh in signaling
(Incardona et al., submitted for publication) suggest impor-
tant functional ties to the structural similarity of Ptc and
NPC1. It is possible that all the compounds indirectly affect
both NPC1 and Ptc by affecting another protein or lipid
with which they have a common functional interaction. On
the other hand, the potency of cyclopamine could reflect an
activity distinct from the other hydrophobic amines and
steroids. Nevertheless, recent studies provided evidence for
regional lipid specializations within endosomal compart-
ments (Kobayashi et al., 1998; Mayor et al., 1998; Mukher-
jee et al., 1999), including a lumenal region of late endo-
somes involved in cholesterol transport that is enriched
with a unique lipid, lysobisphosphatidic acid, and perturbed
by U18666A (Kobayashi et al., 1999). We speculate that the
function of both NPC1 and Ptc may be related to such
intracellular lipid specializations and that the regulation of
Smo activity by Ptc involves vesicular trafficking.
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